Literature DB >> 4016280

Estradiol and progesterone receptors in breast cancer: prognostic value after relapse.

J Bonneterre, D Horner, J P Peyrat, B Vandewalle, L Cambier, A Demaille.   

Abstract

The prognostic significance of estradiol (ER) and progesterone receptors (PgR) for survival from relapse has been studied in two groups of breast cancer patients: group 1, 35 patients in whom receptor levels were measured at the time of mastectomy; group II, 49 patients in whom receptor levels were measured at the time of recurrence. ER+ (greater than 10 fmoles/mg) patients had a better survival from relapse than ER- patients. High levels of PgR (greater than 50 fmoles/mg) had a prognostic significance only in group II patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4016280     DOI: 10.1007/bf01805988

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  14 in total

1.  Specific progesterone receptors in human breast cancer.

Authors:  K B Horwitz; W L McGuire
Journal:  Steroids       Date:  1975-04       Impact factor: 2.668

2.  Standards for the assessment of estrogen receptors in human breast cancer. Report of a workshop on September 29, 1972, at the Antoni van Leeuwenhoek-Huis, Amsterdam.

Authors: 
Journal:  Eur J Cancer       Date:  1973-05       Impact factor: 9.162

Review 3.  The usefulness of steroid hormone receptors in the management of primary and advanced breast cancer.

Authors:  W L McGuire
Journal:  Eur J Cancer       Date:  1980       Impact factor: 9.162

4.  Multiple progesterone receptor assays in human breast cancer.

Authors:  G E Gross; G M Clark; G C Chamness; W L McGuire
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

5.  Progesterone and estrogen receptors as prognostic variables in breast cancer.

Authors:  B H Mason; I M Holdaway; P R Mullins; L H Yee; R G Kay
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

6.  Steroid-hormone receptors and survival after first relapse in breast cancer.

Authors:  A Howell; D M Barnes; R N Harland; J Redford; V H Bramwell; M J Wilkinson; R Swindell; D Crowther; R A Sellwood
Journal:  Lancet       Date:  1984-03-17       Impact factor: 79.321

7.  Prognostic value of estrogen and progesterone receptors in primary breast cancer.

Authors:  S Saez; F Cheix; B Asselain
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

8.  Progesterone receptors as a prognostic factor in Stage II breast cancer.

Authors:  G M Clark; W L McGuire; C A Hubay; O H Pearson; J S Marshall
Journal:  N Engl J Med       Date:  1983-12-01       Impact factor: 91.245

9.  Relationship of presence of progesterone receptors to prognosis in early breast cancer.

Authors:  M F Pichon; C Pallud; M Brunet; E Milgrom
Journal:  Cancer Res       Date:  1980-09       Impact factor: 12.701

10.  Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer.

Authors:  D T Kiang; D H Frenning; A I Goldman; V F Ascensao; B J Kennedy
Journal:  N Engl J Med       Date:  1978-12-14       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.